97 related articles for article (PubMed ID: 23566764)
1. Direct targeting of β-catenin: Inhibition of protein-protein interactions for the inactivation of Wnt signaling.
Hahne G; Grossmann TN
Bioorg Med Chem; 2013 Jul; 21(14):4020-6. PubMed ID: 23566764
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Wnt/β-catenin signaling pathway in human cancers.
Yao H; Ashihara E; Maekawa T
Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
[TBL] [Abstract][Full Text] [Related]
3. An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics.
Takemaru KI; Ohmitsu M; Li FQ
Handb Exp Pharmacol; 2008; (186):261-84. PubMed ID: 18491056
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling as a therapeutic target for cancer.
Herbst A; Kolligs FT
Methods Mol Biol; 2007; 361():63-91. PubMed ID: 17172707
[TBL] [Abstract][Full Text] [Related]
5. Novel regulatory mechanism of canonical Wnt signaling by dopamine D2 receptor through direct interaction with beta-catenin.
Min C; Cho DI; Kwon KJ; Kim KS; Shin CY; Kim KM
Mol Pharmacol; 2011 Jul; 80(1):68-78. PubMed ID: 21493728
[TBL] [Abstract][Full Text] [Related]
6. Wnt signaling and cancer development: therapeutic implication.
Paul S; Dey A
Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
[TBL] [Abstract][Full Text] [Related]
7. Targeting Wnt signaling: can we safely eradicate cancer stem cells?
Takahashi-Yanaga F; Kahn M
Clin Cancer Res; 2010 Jun; 16(12):3153-62. PubMed ID: 20530697
[TBL] [Abstract][Full Text] [Related]
8. Polyethylenimine-cationized beta-catenin protein transduction activates the Wnt canonical signaling pathway more effectively than cationic lipid-based transduction.
Kitazoe M; Futami J; Nishikawa M; Yamada H; Maeda Y
Biotechnol J; 2010 Apr; 5(4):385-92. PubMed ID: 20235145
[TBL] [Abstract][Full Text] [Related]
9. Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins.
Liu X; Rubin JS; Kimmel AR
Curr Biol; 2005 Nov; 15(22):1989-97. PubMed ID: 16303557
[TBL] [Abstract][Full Text] [Related]
10. New avenues to target Wnt/β-catenin signaling.
Verkaar F; Zaman GJ
Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
[TBL] [Abstract][Full Text] [Related]
11. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
12. β-catenin regulates parathyroid hormone/parathyroid hormone-related protein receptor signals and chondrocyte hypertrophy through binding to the intracellular C-terminal region of the receptor.
Yano F; Saito T; Ogata N; Yamazawa T; Iino M; Chung UI; Kawaguchi H
Arthritis Rheum; 2013 Feb; 65(2):429-35. PubMed ID: 23124878
[TBL] [Abstract][Full Text] [Related]
13. Reconstruction and crosstalk of protein-protein interaction networks of Wnt and Hedgehog signaling in Drosophila melanogaster.
Toku AE; Tekir SD; Özbayraktar FB; Ülgen KÖ
Comput Biol Chem; 2011 Oct; 35(5):282-92. PubMed ID: 22000799
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth.
Baryawno N; Sveinbjörnsson B; Eksborg S; Chen CS; Kogner P; Johnsen JI
Cancer Res; 2010 Jan; 70(1):266-76. PubMed ID: 20028853
[TBL] [Abstract][Full Text] [Related]
16. Wnt and calcium signaling: beta-catenin-independent pathways.
Kohn AD; Moon RT
Cell Calcium; 2005; 38(3-4):439-46. PubMed ID: 16099039
[TBL] [Abstract][Full Text] [Related]
17. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
18. The canonical Wnt/β-catenin signaling pathway regulates Fgf signaling for early facial development.
Wang Y; Song L; Zhou CJ
Dev Biol; 2011 Jan; 349(2):250-60. PubMed ID: 21070765
[TBL] [Abstract][Full Text] [Related]
19. Wnt-11 signaling leads to down-regulation of the Wnt/beta-catenin, JNK/AP-1 and NF-kappaB pathways and promotes viability in the CHO-K1 cells.
Railo A; Nagy II; Kilpeläinen P; Vainio S
Exp Cell Res; 2008 Aug; 314(13):2389-99. PubMed ID: 18572162
[TBL] [Abstract][Full Text] [Related]
20. Dual-specificity phosphatases are targets of the Wnt/β-catenin pathway and candidate mediators of β-catenin/Ras signaling interactions.
Zeller E; Mock K; Horn M; Colnot S; Schwarz M; Braeuning A
Biol Chem; 2012 Oct; 393(10):1183-91. PubMed ID: 23089536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]